Comparative Effectiveness of Atypical Antipsychotics in Schizophrenia
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Effectiveness of Atypical Antipsychotics in Schizophrenia
Authors
Keywords
-
Journal
CNS DRUGS
Volume 26, Issue 6, Pages 491-508
Publisher
Springer Nature
Online
2012-06-06
DOI
10.2165/11632020-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antipsychotics and Schizophrenia: From Efficacy and Effectiveness to Clinical Decision-Making
- (2017) George Foussias et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- An Algorithm-Based Approach to First-Episode Schizophrenia
- (2011) Ofer Agid et al. JOURNAL OF CLINICAL PSYCHIATRY
- Relationship Between Daily Dose, Plasma Concentrations, Dopamine Receptor Occupancy, and Clinical Response to Quetiapine
- (2011) Anna Sparshatt et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)
- (2010) Brian L. Strom et al. AMERICAN JOURNAL OF PSYCHIATRY
- Clinical Trials Design Lessons From the CATIE Study
- (2009) Helena Chmura Kraemer et al. AMERICAN JOURNAL OF PSYCHIATRY
- Quetiapine
- (2009) Anna Sparshatt et al. CNS DRUGS
- Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
- (2009) Diego Novick et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)
- (2009) Brian L. Storm et al. JOURNAL OF CLINICAL PSYCHIATRY
- A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia
- (2009) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia
- (2009) Leslie Citrome et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Health-Related Quality of Life (HRQL) and Continuous Antipsychotic Treatment: 3-year Results from the Schizophrenia Health Outcomes (SOHO) Study
- (2009) Jordi Alonso et al. VALUE IN HEALTH
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Extrapyramidal side-effects of antipsychotics in a randomised trial
- (2008) Del D. Miller et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study
- (2008) Josep Maria Haro et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- What CATIE Found: Results From the Schizophrenia Trial
- (2008) M. S. Swartz et al. PSYCHIATRIC SERVICES
- Lessons to Take Home From CATIE
- (2008) W. T. Carpenter et al. PSYCHIATRIC SERVICES
- Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1
- (2008) Jonathan M. Meyer et al. SCHIZOPHRENIA RESEARCH
- Does switching to a new antipsychotic improve outcomes?
- (2008) Robert A Rosenheck et al. SCHIZOPHRENIA RESEARCH
- Results of phase 3 of the CATIE schizophrenia trial
- (2008) T. Scott Stroup et al. SCHIZOPHRENIA RESEARCH
- A Randomized Controlled Trial of the Cost-Utility of Second-Generation Antipsychotics in People with Psychosis and Eligible for Clozapine
- (2008) Linda M. Davies et al. VALUE IN HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation